Sleep apnea raises risk of cardiovascular events and death
New research to be presented at this year’s European Congress on Obesity (ECO 2026, Istanbul, Turkey, 12-15 May)…
Patients who stop GLP-1 drugs often restart or try alternatives
A large real-world study shows that patients who stop popular GLP-1–based weight-loss drugs often return to treatment or…
Most Insomnia Meds Don’t Worsen Sleep Apnea
Summary: Treating insomnia when a patient also has Obstructive Sleep Apnea (OSA)—a condition known as COMISA—is a delicate…
Impurity in Some Compounded Tirzepatide ‘Potentially Dangerous,’ Eli Lilly Warns
Compounded versions of tirzepatide (Mounjaro, Zepbound) containing vitamin B12 pose a potential safety risk to the public, Eli…
How are GLP-1 drugs reshaping treatment for obesity, diabetes, and heart disease?
A sweeping Lancet review reveals how modern incretin-based drugs are reshaping treatment for obesity and diabetes, delivering powerful…
Conch shell blowing lowers apnea events during REM sleep
In a new trial, a centuries-old yogic breathing practice using a conch shell showed measurable benefits for sleep…
Alzheimer’s risk factors look different for men and women
A study of over 6000 patients shows how Alzheimer’s risk is shaped by sex and age of onset,…
Hypoglossal nerve stimulator shows promise for treating sleep apnea in children with Down syndrome
Christopher Hartnick, MD, MS, director of the Division of Pediatric Otolaryngology at Mass Eye and Ear, is the…
Healthy lifestyle factors and recurrent cardiovascular events in patients with OSA: the SAVE study | BMC Medicine
Yeghiazarians Y, Jneid H, Tietjens JR, Redline S, Brown DL, El-Sherif N, et al. Obstructive sleep apnea and…